Profil
Michael W.
Salter is the founder of NoNO, Inc. which was founded in 2003, where he holds the title of Director & Vice President-Finance.
He also worked as a Director at ScarX Therapeutics, Inc.
Aktive Positionen von Michael W. Salter
| Unternehmen | Position | Beginn |
|---|---|---|
NoNO, Inc.
 NoNO, Inc. Pharmaceuticals: MajorHealth Technology NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada. | Gründer | 01.01.2003 |
Ehemalige bekannte Positionen von Michael W. Salter
| Unternehmen | Position | Ende |
|---|---|---|
ScarX Therapeutics, Inc.
 ScarX Therapeutics, Inc. BiotechnologyHealth Technology ScarX Therapeutics, Inc. engages in the provision of biotechnology services. It discovers and develops innovative treatments for dermal scarring. The company was founded by Benjamin Alman in 2012 and is headquartered in Ontario, Canada. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
NoNO, Inc.
NoNO, Inc. Pharmaceuticals: MajorHealth Technology NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada. | Health Technology |
ScarX Therapeutics, Inc.
ScarX Therapeutics, Inc. BiotechnologyHealth Technology ScarX Therapeutics, Inc. engages in the provision of biotechnology services. It discovers and develops innovative treatments for dermal scarring. The company was founded by Benjamin Alman in 2012 and is headquartered in Ontario, Canada. | Health Technology |
